Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease

Jahr

2022

Autoren

Ziemssen T, Smolinski L, Członkowska A, Akgun K, Antos A, Bembenek J, Kurkowska-Jastrzębska I, Przybyłkowski A, Skowrońska M, Redzia-Ogrodnik B, Litwin T.

Verlag

Acta Neurol Belg. 2023 Jun;123(3):917-925.

Link

https://doi.org/10.1007/s13760-022-02091-z

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease

Modelling the effect of demographic change and healthcare infrastructure on the patient structure in German hospitals – a longitudinal national study based on official hospital statistics

Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis

Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination

Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: Toward a clinical blood test for neuronal injury

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy